Gemcitabine for Marginal Zone Lymphoma

NCT00337259 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

43

Enrollment

OTHER

Sponsor class

Stopped poor accrual and response less than expected on interim analysis

Conditions

Non-Hodgkin's Lymphoma
Marginal Zone Lymphoma

Interventions

DRUG: gemcitabine

Sponsor

Asan Medical Center

Collaborators

[object Object]